methyl 2-[[8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]methyl]-5-bromobenzoate

C24H27BrN6O4 — CID 155531169

IUPACmethyl 2-[[8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]methyl]-5-bromobenzoate
SMILESCC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(Br)cc1C(=O)OC)c(=O)n2C
InChIInChI=1S/C24H27BrN6O4/c1-4-5-11-30-19-20(27-23(30)29-10-6-7-17(26)14-29)28(2)24(34)31(21(19)32)13-15-8-9-16(25)12-18(15)22(33)35-3/h8-9,12,17H,6-7,10-11,13-14,26H2,1-3H3/t17-/m1/s1
InChIKeyMFPOWIWYYFVDCZ-QGZVFWFLSA-N
MW543.42 g/mol
LogP1.44
Rot. Bonds5

About methyl 2-[[8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]methyl]-5-bromobenzoate

methyl 2-[[8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]methyl]-5-bromobenzoate (PubChem CID 155531169) has the molecular formula C24H27BrN6O4 and a molecular weight of 543.42 g/mol. Its IUPAC name is methyl 2-[[8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]methyl]-5-bromobenzoate.

Molecular Properties

Compound Namemethyl 2-[[8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]methyl]-5-bromobenzoate
PubChem CID155531169
Molecular FormulaC24H27BrN6O4
Molecular Weight543.42 g/mol
Exact Mass542.13
IUPAC Namemethyl 2-[[8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]methyl]-5-bromobenzoate
SMILESCC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(Br)cc1C(=O)OC)c(=O)n2C
InChIInChI=1S/C24H27BrN6O4/c1-4-5-11-30-19-20(27-23(30)29-10-6-7-17(26)14-29)28(2)24(34)31(21(19)32)13-15-8-9-16(25)12-18(15)22(33)35-3/h8-9,12,17H,6-7,10-11,13-14,26H2,1-3H3/t17-/m1/s1
InChIKeyMFPOWIWYYFVDCZ-QGZVFWFLSA-N
XLogP1.44
TPSA117.38 Ų
H-Bond Donors1
H-Bond Acceptors10
Rotatable Bonds5
Heavy Atoms35
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500543.42
LogP ≤ 51.44
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze methyl 2-[[8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]methyl]-5-bromobenzoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of methyl 2-[[8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]methyl]-5-bromobenzoate?
The IUPAC name of methyl 2-[[8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]methyl]-5-bromobenzoate (CID 155531169) is methyl 2-[[8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]methyl]-5-bromobenzoate.
What is the SMILES notation for methyl 2-[[8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]methyl]-5-bromobenzoate?
The canonical SMILES for methyl 2-[[8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]methyl]-5-bromobenzoate is CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1ccc(Br)cc1C(=O)OC)c(=O)n2C.
What is the InChIKey of methyl 2-[[8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]methyl]-5-bromobenzoate?
The InChIKey is MFPOWIWYYFVDCZ-QGZVFWFLSA-N. The full InChI is InChI=1S/C24H27BrN6O4/c1-4-5-11-30-19-20(27-23(30)29-10-6-7-17(26)14-29)28(2)24(34)31(21(19)32)13-15-8-9-16(25)12-18(15)22(33)35-3/h8-9,12,17H,6-7,10-11,13-14,26H2,1-3H3/t17-/m1/s1.
What are the key properties of methyl 2-[[8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]methyl]-5-bromobenzoate?
methyl 2-[[8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]methyl]-5-bromobenzoate has a molecular weight of 543.42 g/mol, XLogP of 1.44, 5 rotatable bonds, 1 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for methyl 2-[[8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]methyl]-5-bromobenzoate is sourced from PubChem (CID 155531169), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).